Cargando…
Statistical analysis plan for the Dex-CSDH trial: a randomised, double-blind, placebo-controlled trial of a 2-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma
BACKGROUND: The incidence of chronic subdural haematoma (CSDH) is increasing. Although surgery remains the mainstay of management for symptomatic patients, uncertainty remains regarding the role of steroids. Hence, the Dex-CSDH trial was launched in the UK in 2015 aiming to determine whether, compar...
Autores principales: | Allison, Annabel, Edlmann, Ellie, Kolias, Angelos G., Davis-Wilkie, Carol, Mee, Harry, Thelin, Eric P., Turner, Carole, Hutchinson, Peter J., Bond, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905057/ https://www.ncbi.nlm.nih.gov/pubmed/31822298 http://dx.doi.org/10.1186/s13063-019-3866-6 |
Ejemplares similares
-
Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
por: Kolias, Angelos G., et al.
Publicado: (2018) -
Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
por: Kolias, Angelos G., et al.
Publicado: (2019) -
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase
por: Edlmann, Ellie, et al.
Publicado: (2019) -
Study Protocol on Defining Core Outcomes and Data Elements in Chronic Subdural Haematoma
por: Holl, Dana C, et al.
Publicado: (2021) -
Can compliment and complaint data inform the care of individuals with chronic subdural haematoma (cSDH)?
por: Jones, Katherine, et al.
Publicado: (2021)